Progyny Appoints New CMO, Elects Director
Ticker: PGNY · Form: 8-K · Filed: Apr 11, 2025 · CIK: 1551306
| Field | Detail |
|---|---|
| Company | Progyny, Inc. (PGNY) |
| Form Type | 8-K |
| Filed Date | Apr 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-appointment, board-election, management-change
TL;DR
Progyny brings in a new CMO and adds a director to the board.
AI Summary
On April 9, 2025, Progyny, Inc. announced the appointment of Dr. Mark J. Ratner as Chief Medical Officer and the election of Ms. Karen M. King to its Board of Directors. Dr. Ratner's appointment is effective immediately, and Ms. King's election is also effective immediately. The company also disclosed compensatory arrangements for certain officers.
Why It Matters
These executive and board changes could signal shifts in the company's strategic direction or leadership focus, potentially impacting its future growth and operations in the fertility benefits management sector.
Risk Assessment
Risk Level: low — The filing reports routine executive and board changes, which are common corporate events and do not inherently indicate significant financial or operational risks.
Key Players & Entities
- Progyny, Inc. (company) — Registrant
- Dr. Mark J. Ratner (person) — Appointed Chief Medical Officer
- Ms. Karen M. King (person) — Elected to Board of Directors
- April 9, 2025 (date) — Date of earliest event reported
FAQ
What is the effective date of Dr. Mark J. Ratner's appointment as Chief Medical Officer?
Dr. Mark J. Ratner's appointment as Chief Medical Officer is effective immediately as of April 9, 2025.
Who has been elected to Progyny, Inc.'s Board of Directors?
Ms. Karen M. King has been elected to Progyny, Inc.'s Board of Directors, effective immediately as of April 9, 2025.
What is the primary purpose of this 8-K filing?
This 8-K filing reports the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
What is Progyny, Inc.'s principal executive office address?
Progyny, Inc.'s principal executive office is located at 1359 Broadway, New York, New York 10018.
When was Progyny, Inc. incorporated?
Progyny, Inc. was incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 11, 2025 by Dr. Mark J. Ratner regarding Progyny, Inc. (PGNY).